Ceftriaxone Dosing in Pediatric Patients
For pediatric patients, ceftriaxone should be administered at 50-75 mg/kg/day once daily or divided every 12-24 hours for most infections, with dosage adjustments based on infection severity, site, and patient age. 1, 2
Age-Specific Dosing
- For neonates ≤7 days of age: 50 mg/kg/day given every 24 hours 1
- For neonates >7 days and ≤2000 g: 50 mg/kg/day given every 24 hours 1
- For neonates >7 days and >2000 g: 50-75 mg/kg/day given every 24 hours 1
- Ceftriaxone should not be used in hyperbilirubinemic neonates due to risk of bilirubin encephalopathy 1, 2
Indication-Specific Dosing
Meningitis
- 100 mg/kg/day divided every 12-24 hours (maximum 4 g daily) 1, 2
- Intravenous administration over 60 minutes in neonates to reduce risk of bilirubin encephalopathy 2
- Duration of therapy typically 7-14 days 2, 3
Respiratory Infections
- For pneumonia: 50-100 mg/kg/day once daily or divided every 12-24 hours 1, 4
- For pneumococcal pneumonia with penicillin resistance: 100 mg/kg/day given every 12-24 hours 1, 5
Skin and Soft Tissue Infections
Otitis Media
- Single intramuscular dose of 50 mg/kg (not to exceed 1 gram) 2
Other Serious Infections
- For bacteremia or arthritis: 50 mg/kg/day given daily for 7 days 1
- For complicated intra-abdominal infections and sepsis: 50-75 mg/kg/day given every 12-24 hours 1
- For gonococcal conjunctivitis in children ≤45 kg: 25-50 mg/kg IV or IM as a single dose (maximum 250 mg) 1
Pathogen-Specific Considerations
- For gram-negative enteric bacilli: 100 mg/kg/day divided every 12 hours or 80 mg/kg/day every 24 hours (maximum 4 g daily) 1
- For Streptococcus pneumoniae with penicillin MIC <2.0 μg/mL: 50-100 mg/kg/day every 12-24 hours 5
- For penicillin-resistant Streptococcus pneumoniae (MIC ≥4.0 μg/mL): 100 mg/kg/day every 12-24 hours 5
- For Haemophilus influenzae (β-lactamase producing): 50-100 mg/kg/day every 12-24 hours 5, 7
Administration Guidelines
- Intravenous doses should be administered over 30 minutes in pediatric patients 2
- In neonates, administer over 60 minutes to reduce risk of bilirubin encephalopathy 2
- For IV administration, reconstitute to concentrations between 10-40 mg/mL 2
- Do not use diluents containing calcium (e.g., Ringer's solution) due to risk of particulate formation 2
Clinical Efficacy and Safety
- Once-daily administration (50-80 mg/kg) has demonstrated 94-96% clinical cure rates in serious pediatric infections 7, 6
- Bacteriologic cure rates of 90-98% have been reported with once-daily dosing 7, 3, 8
- Common side effects include gastrointestinal symptoms and transient neutropenia 6
Important Considerations
- Duration of therapy typically ranges from 4-14 days depending on infection type and severity 2
- For Streptococcus pyogenes infections, treatment should continue for at least 10 days 2
- Once-daily dosing provides similar efficacy to divided doses with greater convenience 4, 6
- No dosage adjustment is necessary for patients with renal or hepatic impairment unless severe 2